Class of Anticonvulsants
Treponema pallidum Antibody by TP-PA, Serum
Branched-Chain Amino Acids for Maple Syrup Disease Monitoring
5'-Nucleotidase
Valproic Acid, Total, Serum
Alpha 1 Antitrypsin Genotyping/Phenotyping
G-protein gated Inwardly Rectifying K+ channel 1 (GIRK1) Genotyping
Infectious Mononucleosis Screen (Mono Test)
HLA DQ Genotyping for Celiac Disease
The Enhanced Liver Fibrosis (ELF)
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
ICD10
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now
Loading...